Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraphobia.

Marazziti D, Carlini M, Dell'Osso L.

Curr Top Med Chem. 2012;12(4):238-53. Review.

PMID:
22204483
2.

WCA recommendations for the long-term treatment of panic disorder.

Pollack MH, Allgulander C, Bandelow B, Cassano GB, Greist JH, Hollander E, Nutt DJ, Okasha A, Swinson RP; World Council of Anxiety.

CNS Spectr. 2003 Aug;8(8 Suppl 1):17-30. Review.

PMID:
14767395
3.

Integrated treatment of panic disorder.

Rosenbaum JF, Pollock RA, Otto MW, Pollack MH.

Bull Menninger Clin. 1995 Spring;59(2 Suppl A):A4-26. Review.

PMID:
7795571
4.

[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].

Kordon A, Broocks A, Hohagen F.

MMW Fortschr Med. 2003 May 26;145 Suppl 2:4-7. Review. German.

PMID:
14579475
5.

The medical treatment of obsessive-compulsive disorder and anxiety.

Bandelow B.

CNS Spectr. 2008 Sep;13(9 Suppl 14):37-46. Review.

PMID:
18849910
6.

Diagnosis and treatment of obsessive-compulsive disorder and related disorders.

Dell'Osso B, Altamura AC, Mundo E, Marazziti D, Hollander E.

Int J Clin Pract. 2007 Jan;61(1):98-104. Review.

PMID:
17229184
7.

Pharmacotherapeutic considerations in anxiety disorders.

Hollister LE.

J Clin Psychiatry. 1986 Jun;47 Suppl:33-6. Review.

PMID:
2872208
8.

Treatment-resistant panic disorder.

Bandelow B, Rüther E.

CNS Spectr. 2004 Oct;9(10):725-39. Review.

PMID:
15448584
9.

[Panic attacks and panic disorder. Checklist for the diagnosis].

Boerner RJ.

MMW Fortschr Med. 2003 May 26;145 Suppl 2:9-12. Review. German.

PMID:
14579476
10.

Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.

Zohar J, Westenberg HG.

Acta Psychiatr Scand Suppl. 2000;403:39-49. Review.

PMID:
11019934
11.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
12.

[Biological treatments in obsessive-compulsive disorder].

Montgomery SA, Fineberg NA, Montgomery D.

Encephale. 1990 Jul-Aug;16 Spec No:335-9. Review. French.

PMID:
2209492
13.

Overview of diagnosis and drug treatments of anxiety disorders.

Nutt DJ.

CNS Spectr. 2005 Jan;10(1):49-56. Review.

PMID:
15618947
14.

SSRIs and SNRIs: broad spectrum of efficacy beyond major depression.

Gorman JM, Kent JM.

J Clin Psychiatry. 1999;60 Suppl 4:33-8; discussion 39. Review.

15.

Recent developments in the psychopharmacology of anxiety disorders.

Lydiard RB, Brawman-Mintzer O, Ballenger JC.

J Consult Clin Psychol. 1996 Aug;64(4):660-8. Review.

PMID:
8803355
16.
17.

Generalized anxiety disorder.

Hoehn-Saric R, McLeod DR.

Psychiatr Clin North Am. 1985 Mar;8(1):73-88. Review.

PMID:
2859581
18.

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders.

Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ; World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders.

World J Biol Psychiatry. 2002 Oct;3(4):171-99. Review.

PMID:
12516310
19.

WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults.

Greist JH, Bandelow B, Hollander E, Marazziti D, Montgomery SA, Nutt DJ, Okasha A, Swinson RP, Zohar J; World Council of Anxiety.

CNS Spectr. 2003 Aug;8(8 Suppl 1):7-16. Review.

PMID:
14767394
20.

Pharmacotherapy of panic disorder: differential efficacy from a clinical viewpoint.

den Boer JA.

J Clin Psychiatry. 1998;59 Suppl 8:30-6; discussion 37-8. Review.

Supplemental Content

Support Center